The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
2016 European guideline on Mycoplasma genitalium infections
Open accessAbstract
Mycoplasma genitalium infection contributes to 10–35% of non‐chlamydial non‐gonococcal urethritis in men. In women, M. genitalium is associated with cervicitis and pelvic inflammatory disease (PID). Transmission of M. genitalium occurs through direct mucosal contact. Asymptomatic infections are frequent. In women, symptoms include vaginal discharge, dysuria or symptoms of PID – abdominal pain and dyspareunia. In men, urethritis, dysuria and discharge predominates. Besides symptoms, indication for laboratory test is a high‐risk sexual behaviour. Diagnosis is achievable only through nucleic acid amplification testing (NAAT). If available, NAAT diagnosis should be followed with an assay for macrolide resistance. Therapy for M. genitalium is indicated if M. genitalium is detected or on an epidemiological basis. Doxycycline has a low cure rate of 30–40%, but does not increase resistance. Azithromycin has a cure rate of 85–95% in macrolide susceptible infections. An extended course appears to have a higher cure rate. An increasing prevalence of macrolide resistance, most likely due to widespread use of azithromycin 1 g single dose without test of cure, is drastically decreasing the cure rate. Moxifloxacin can be used as second‐line therapy, but resistance is increasing. Uncomplicated M. genitalium infection should be treated with azithromycin 500 mg on day one, then 250 mg on days 2–5 (oral), or josamycin 500 mg three times daily for 10 days (oral). Second line treatment and treatment for uncomplicated macrolide resistant M. genitalium infection is moxifloxacin 400 mg od for 7–10 days (oral). For third line treatment of persistent M. genitalium infection after azithromycin and moxifloxacin doxycycline 100 mg two times daily for 14 days can be tried and may cure 30%. Pristinamycin 1 g four times daily for 10 days (oral) has a cure rate of app. 90%. Complicated M. genitalium infection (PID, epididymitis) is treated with moxifloxacin 400 mg od for 14 days.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sexually transmitted diseases treatment guidelines (2015)
Workowski, K., & BOLAN, G. A. (2015) · Reproductive Endocrinology · doi:10.18370/2309-4117.2015.24.51-56 · Cited by 2,698
Sexually Transmitted Diseases Treatment Guidelines 2002
(2002) · PsycEXTRA Dataset · doi:10.1037/e548482006-001 · Cited by 1,237
A NEWLY DISCOVERED MYCOPLASMA IN THE HUMAN UROGENITAL TRACT
Tully, J., Cole, R., Taylor-Robinson, D., & Rose, D. (1981) · The Lancet · doi:10.1016/s0140-6736(81)92461-2 · Cited by 576
Mycoplasma genitalium: from Chrysalis to Multicolored Butterfly
Taylor-Robinson, D., & Jensen, J. S. (2011) · Clinical Microbiology Reviews · doi:10.1128/cmr.00006-11 · Cited by 537
Self-citationMycoplasma genitalium Infection and Female Reproductive Tract Disease: A Meta-analysis
Lis, R., Rowhani-Rahbar, A., & Manhart, L. E. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ312 · Cited by 460
Jensen, J. S., Bradshaw, C. S., Tabrizi, S. N., Fairley, C. K., & Hamasuna, R. (2008) · Clinical Infectious Diseases · doi:10.1086/593188 · Cited by 338
Self-citationAssociation between Mycoplasma genitalium and acute endometritis
Cohen, C. R., Manhart, L. E., Bukusi, E. A., Astete, S., Brunham, R. C., Holmes, K. K., Sinei, S. K., Bwayo, J. J., & Totten, P. A. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07848-0 · Cited by 307
Mucopurulent Cervicitis and Mycoplasma genitalium
Manhart, L. E., Critchlow, C. W., Holmes, K. K., Dutro, S. M., Eschenbach, D. A., Stevens, C. E., & Totten, P. A. (2003) · The Journal of Infectious Diseases · doi:10.1086/367992 · Cited by 275
Mycoplasma genitalium: prevalence, clinical significance, and transmission
Anagrius, C. (2005) · Sexually Transmitted Infections · doi:10.1136/sti.2004.012062 · Cited by 235
Schwebke, J. R., Rompalo, A., Taylor, S., Sena, A. C., Martin, D. H., Lopez, L. M., Lensing, S., & Lee, J. Y. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/ciq074 · Cited by 235
Cited by
Machalek, D. A., Tao, Y., Shilling, H., Jensen, J. S., Unemo, M., Murray, G., Chow, E. P. F., Low, N., Garland, S. M., Vodstrcil, L. A., et al. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30154-7 · Cited by 273
Self-citation2021 European guideline on the management of Mycoplasma genitalium infections
Jensen, J. S., Cusini, M., Gomberg, M., Moi, H., Wilson, J., & Unemo, M. (2022) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.17972 · Cited by 255
Self-citationBaumann, L., Cina, M., Egli-Gany, D., Goutaki, M., Halbeisen, F. S., Lohrer, G.-R., Ali, H., Scott, P., & Low, N. (2018) · Sexually Transmitted Infections · doi:10.1136/sextrans-2017-053384 · Cited by 253
Antibiotics for treating urogenital Chlamydia trachomatis infection in men and non-pregnant women
Páez-Canro, C., Alzate, J. P., González, L. M., Rubio-Romero, J. A., Lethaby, A., & Gaitán, H. G. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010871.pub2 · Cited by 42
Metadata
- Authors
- Jensen, J. S., Cusini, M., Gomberg, M., & Moi, H.
- Venue
- Journal of the European Academy of Dermatology and Venereology
- Publisher
- Wiley
- Published
- 2016-08-09
- Volume
- 30
- Issue
- 10
- Pages
- 1650-1656
- ISSN
- 0926-9959 (ISSN-L)
- 1468-3083
- OpenAlex
- W2513940066
- Cited by
- 343
- References
- 50
- FWCI
- 39.32
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: 2016 European guideline on Mycoplasma genitalium infections. https://app.cochat.ai/papers/10.1111/jdv.13849
- The paper
- Jensen, J. S., Cusini, M., Gomberg, M., & Moi, H. (2016). 2016 European guideline on Mycoplasma genitalium infections. Journal of the European Academy of Dermatology and Venereology. https://doi.org/10.1111/jdv.13849
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.